Chu Vision Institute Revenue and Competitors
Estimated Revenue & Valuation
- Chu Vision Institute's estimated annual revenue is currently $13.4M per year.
- Chu Vision Institute's estimated revenue per employee is $243,000
Employee Data
- Chu Vision Institute has 55 Employees.
- Chu Vision Institute grew their employee count by 4% last year.
Chu Vision Institute's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO and Chief Medical Officer | Reveal Email/Phone |
2 | VP Clinical Research and Regulatory Affairs | Reveal Email/Phone |
3 | EVP Operations | Reveal Email/Phone |
4 | Chief Financial Officer | Reveal Email/Phone |
5 | Project Manager | Reveal Email/Phone |
6 | Clinic Manager, RN | Reveal Email/Phone |
7 | Patient Care Specialist | Reveal Email/Phone |
8 | Patient Care Concierge | Reveal Email/Phone |
9 | Registered Nurse | Reveal Email/Phone |
10 | Patient Care Specialist | Reveal Email/Phone |
Chu Vision Institute Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.3M | 34 | 6% | N/A | N/A |
#2 | $279320M | 151713 | -45% | N/A | N/A |
#3 | $0.4M | 3 | 200% | N/A | N/A |
#4 | $15.3M | 63 | 7% | N/A | N/A |
#5 | $13.4M | 55 | -4% | N/A | N/A |
#6 | $72.8M | 245 | 10% | N/A | N/A |
#7 | $10.4M | 48 | 4% | N/A | N/A |
#8 | $8.9M | 41 | -5% | N/A | N/A |
#9 | $14.3M | 59 | 11% | N/A | N/A |
#10 | $8.6M | 40 | -11% | N/A | N/A |
What Is Chu Vision Institute?
Chu Vision Institute is one of the top laser-vision surgery centers in the US. Chu Vision Institute specializes in laser vision correction, cataracts, glaucoma and dry eye syndrome.
keywords:N/AN/A
Total Funding
55
Number of Employees
$13.4M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5M | 55 | 4% | N/A |
#2 | $13.4M | 55 | 25% | N/A |
#3 | $12.4M | 55 | N/A | N/A |
#4 | $7.5M | 56 | 2% | N/A |
#5 | $9.1M | 56 | 12% | N/A |